home / stock / achff / achff quote
Last: | $1.14 |
---|---|
Change Percent: | -1.75% |
Open: | $1.16 |
Close: | $1.14 |
High: | $1.16 |
Low: | $1.13 |
Volume: | 12,200 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.14 | $1.16 | $1.14 | $1.16 | $1.13 | 12,200 | 07-19-2024 |
$1.14 | $1.17 | $1.14 | $1.17 | $1.1301 | 3,900 | 07-18-2024 |
$1.16 | $1.175 | $1.16 | $1.175 | $1.16 | 4,400 | 07-17-2024 |
$1.1901 | $1.2 | $1.1901 | $1.2 | $1.19 | 1,800 | 07-15-2024 |
$1.195 | $1.192 | $1.195 | $1.195 | $1.192 | 1,500 | 07-12-2024 |
$1.19 | $1.24 | $1.19 | $1.24 | $1.18 | 6,300 | 07-11-2024 |
$1.22 | $1.24 | $1.22 | $1.24 | $1.22 | 2,100 | 07-10-2024 |
$1.205 | $1.2 | $1.205 | $1.215 | $1.2 | 10,900 | 07-09-2024 |
$1.22 | $1.22 | $1.22 | $1.24 | $1.21 | 14,300 | 07-08-2024 |
$1.2301 | $1.23 | $1.2301 | $1.249 | $1.21 | 28,300 | 07-05-2024 |
$1.215 | $1.22 | $1.215 | $1.24 | $1.215 | 8,900 | 07-04-2024 |
$1.215 | $1.22 | $1.215 | $1.24 | $1.215 | 8,900 | 07-03-2024 |
$1.21 | $1.23 | $1.21 | $1.23 | $1.2016 | 11,990 | 07-02-2024 |
$1.225 | $1.2243 | $1.225 | $1.225 | $1.22 | 8,300 | 07-01-2024 |
$1.22 | $1.22 | $1.22 | $1.22 | $1.22 | 680 | 06-27-2024 |
$1.17 | $1.2 | $1.17 | $1.2 | $1.17 | 8,800 | 06-26-2024 |
$1.22 | $1.21 | $1.22 | $1.22 | $1.21 | 1,500 | 06-25-2024 |
$1.18 | $1.21 | $1.18 | $1.21 | $1.18 | 17,900 | 06-24-2024 |
$1.21 | $1.25 | $1.21 | $1.26 | $1.18 | 7,600 | 06-21-2024 |
$1.25 | $1.23 | $1.25 | $1.25 | $1.2201 | 11,155 | 06-20-2024 |
News, Short Squeeze, Breakout and More Instantly...
Arch Biopartners Inc Company Name:
ACHFF Stock Symbol:
OTCMKTS Market:
Arch Biopartners Inc Website:
TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced that Dalton Pharma Services (Dalton) has completed the good manufacturing practice (GMP) glass vial filling stage for cilast...
TORONTO, June 18, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the University of Calgary’s Conjoint Health Research Ethics Board (CHREB) has approved the Phase II trial ...
Yoshiharu Global Co. (YOSH) is expected to report for Q1 2024 Analog Devices Inc. (ADI) is expected to report $1.26 for Q2 2024 Simplicity Esports (WINR) is expected to report for Q3 2024 Klepierre (KLPEF) is expected to report for Q1 2024 Synopsys Inc. (SNPS) is expected to repor...